Cyclin-dependent kinase (CDK) 2 inhibition plays a central role in DNA damage-induced cell cycle arrest and DNA repair. However, whether CDK2 also influences early porcine embryo development is unknown. In this study, we examined whether CDK2 is involved in the regulation of oocyte meiosis and early embryonic development of porcine embryos. We found that disrupting CDK2 activity with RNAi or an inhibitor did not affect meiotic resumption or meiosis II arrest. However, CDK2 inhibitor-treated embryos showed delayed cleavage and ceased development before the blastocyst stage. Disrupting CDK2 activity is able to induce sustained DNA damage, as demonstrated by the formation of distinct gammaH2AX foci in nuclei of Day-3 and Day-5 embryos. Inhibiting CDK2 triggers a DNA damage checkpoint by activation of the ataxia telangiectasia mutated (ATM)-P53-P21 pathway. However, the mRNA expression of genes involved in nonhomologous end joining or homologous recombination pathways for double-strand break repair were reduced after administering CDK2 inhibitor to 5-day-old embryos. Furthermore, CDK2 inhibition caused apoptosis in Day-7 blastocysts. Thus, our results indicate that an ATM-P53-P21 DNA damage checkpoint is intact in the absence of CDK2; however, CDK2 is important for proper repair of the damaged DNA by either directly or indirectly influencing DNA repair-related gene expression.
INTRODUCTION
Cyclin-dependent kinase (CDK) 2 is thought to be essential for the mammalian cell cycle by driving cells through the G1/S transition (in association with cyclin E) and promoting progression through the S phase (in association with cyclin A) [1] [2] [3] . CDK2 is a key regulator of DNA damage-activated G1 phase and intra-S phase checkpoints [4] . In response to DNA damage, mammalian cells activate checkpoint pathways that induce cell cycle delay or arrest [5] . Delayed cell cycle progression allows time for either the repair of DNA damage or the elimination of genetically unstable cells by apoptosis [2, 3] . DNA damage leads to the activation of several protein kinases, such as ataxia telangiectasia mutated (ATM), ataxia telangiectasia and RAD3 related (ATR), and checkpoint kinase 2 (CHK2) [6, 7] . Eventually, the P53-dependent transcription of either CDK inhibitor P21 or ubiquitin-dependent degradation of protein phosphatase CDC25A, or both, occurs [8] [9] [10] , thereby inhibiting CDK2 activity and DNA replication. However, it is not clear whether CDK2 plays a role in the regulation of DNA damage checkpoints during early embryonic development.
In mammals, two molecular pathways are involved in DNA double-strand break (DSB) repair: homologous recombination (HR) and nonhomologous end joining (NHEJ) [11, 12] . In response to DNA damage, activated ATM and ATR can also phosphorylate histone H2AX (cH2AX) at the sites of DSB formation [13] . This phosphorylation involves large chromatin domains forming nuclear foci that are easily detected by immunostaining [14] . The phosphorylation of histone H2AX is critical for DSB repair, because H2AX anchors important initiator proteins that are required for both the HR (e.g., RAD51, MRE11A, BRCA1) and NHEJ (e.g., 53BP1, PRKDC, XRCC6) pathways, which can be colocalized with cH2AX at the DSB sites [15, 16] . After DSBs are repaired, the checkpoint proteins become inactivated to allow cell cycle progression to resume. Previous studies demonstrated that cyclin A1 is essential for DNA DSB repair and that the repair function of cyclin A1 depends on CDK2 [17] . The G1/S DNA damage checkpoint is intact in the absence of CDK2, and P21 inhibits CDK1 in the absence of CDK2 to maintain the G1/S phase DNA damage checkpoint; however, CDK2 is important for proper repair of the damaged DNA [18] . Nevertheless, the activity of DNA DSB repair machinery in the absence of CDK2 has not yet been studied.
Given that much of the mitotic cell cycle machinery is also utilized in meiosis, findings from biochemical studies of mitosis are quite often generalized to meiosis [19, 20] . However, several peculiarities have recently been found in meiosis [21] . For example, although CDK2 knockout mice are viable, deletion of CDK2 in mice leads to a postnatal loss of all oocytes, indicating that CDK2 is important for oocyte survival and, likely, oocyte meiosis [22, 23] . Previous studies showed that, in porcine oocytes, blocking CDK2 activity with an anti-CDK2 antibody resulted in failure to enter the second phase of meiosis [24] . In addition, CDK2 knockout mouse spermatocytes exhibit abnormal homologous pairing, recombination, and sex-body formation [1] . Murine CDK2 knockout oocytes die during the transition from the pachytene stage to the diplotene stage of prophase I, indicating that CDK2 is important for the early stages of oocyte development and meiosis.
Here, we hypothesized that CDK2 might be involved in porcine oocyte maturation and embryo development. Because the porcine reproductive system is similar to the human system, the porcine model is appropriate to study human reproduction [25] . Moreover, the durations of porcine oocyte maturation and initial embryo development are very similar to the analogous events in humans [26, 27] . Furthermore, phylogenetic analysis of proteins that are involved in fertilization or embryonic development revealed that human oocytes or embryos are more closely related to porcine oocytes or embryos than murine oocytes [26] [27] [28] . Our current results indicate the critical roles of CDK2 during porcine early embryo development via its regulatory roles in DNA damage checkpoints and DNA repair; however, there is no identified CDK2 function for meiotic resumption or meiosis (M) II arrest in porcine oocytes.
MATERIALS AND METHODS

Oocyte Collection and Culture
All animal studies were performed after receiving the approval of the Institutional Animal Care and Use Committee of Chungbuk National University, Korea. All chemicals used in this study were purchased from Sigma-Aldrich, unless otherwise stated. Porcine ovaries were provided by a local slaughterhouse (Farm Story Dodarm B&F; Umsung) and were transported to our laboratory at 258C in Dulbecco PBS supplemented with 75 lg/L penicillin G and 50 lg/L streptomycin sulfate. Cumulus-oocyte complexes (COCs) were aspirated from follicles (approximately 2-8 mm in diameter) and were washed three times with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes)-buffered Tyrodes medium containing 0.1% (w/v) polyvinyl alcohol (PVA). The collected COCs were matured in tissue culture medium 199 (Gibco) supplemented with 0.1 g/L sodium pyruvate, 0.6 mM L-cysteine, 10 ng/ml epidermal growth factor, 10% porcine follicular fluid (v/v), 10 IU/ml luteinizing hormone, and 10 IU/ml follicle-stimulating hormone for 44 h at 38.58C in 5% CO 2 and humidified air. After maturation, cumulus cells were removed by pipetting in the presence of 0.1% hyaluronidase (w/v) for 2-3 min.
Oocyte Activation and Embryo Culture
The oocytes were activated parthenogenetically by an electric pulse (1.0 kV/ cm for 60 msec) in activation medium (280 mM mannitol, 0.01 mM CaCl 2 , and 0.05 mM MgCl 2 ), followed by 3 h of incubation in PZM-5 medium containing 2 mM cytochalasin B (Sigma). The embryos were then washed several times in PZM-5 supplemented with 0.4% (w/v) bovine serum albumin (BSA) and cultured in a humidified atmosphere of 5% CO 2 and 95% air at 38.58C.
In Vitro Fertilization
Matured oocytes were washed thrice with in vitro fertilization (IVF) medium (113.1 mM NaCl, 3 mM KCl, 7.5 mM CaCl 2 , 20 mM Tris, 11 mM glucose, 5 mM sodium pyruvate, 2.5 mM caffeine, and 0.1% BSA). Groups of 20 oocytes were then placed in 50-ll drops of IVF medium. Spermatozoa were prepared from fresh semen samples of a proven fertile boar. The spermatozoa were washed twice with IVF medium by centrifugation (1200 rpm) for 3 min, and the sperm pellet was resuspended in IVF medium. Oocytes in each drop were fertilized by adding 5 ll of the sperm preparation with the concentration adjusted to 10 000 spermatozoa per oocyte. The oocytes were coincubated with the sperm for 4 h and then collected, washed twice to remove unattached sperm cells, and then cultured in PZM-5 medium.
Drug Treatment
CDK2 inhibitor II (Santa Cruz Biotechnology) was used as a CDK2-selective inhibitor. To investigate the function of CDK2, CDK2 inhibitor II (10 mM stock in dimethyl sulfoxide [DMSO] , stored at 48C until required) was added to the IVM or IVC medium to a final concentration of 0 (control), 2.5, 5, or 10 lM.
Cdk2 Double-Stranded RNA Preparation
To prepare the Cdk2 double-stranded (ds) RNA for knockdown experiments, a 591-bp DNA fragment of Cdk2 cDNA was amplified using a pair of primers with the T7 promoter sequence GAATTAATA CGACTCAC-TATAGGGAGA at both 5 0 ends. The purified PCR amplicons were then used to synthesize dsRNA with the MEGAscript T7 Kit (AM1333; Ambion). The reaction system was incubated at 378C overnight and then incubated at 758C for 5 min. Finally, the reaction system was cooled to room temperature (RT) for 4 h. The dsRNA was then frozen at À808C until microinjection.
Microinjection
Microinjections were performed using an Eppendorf microinjector and a Nikon Diaphot ECLIPSE TE300 inverted microscope (Nikon U.K. Ltd.) equipped with a Narishige MM0-202N hydraulic three-dimensional micromanipulator (Narishige Inc.) and completed within 1 h. For depleting Cdk2 in germinal vesicle (GV) oocytes, 10 pl (1 lg/ll) of dsRNA was microinjected into the cytoplasm of the oocytes. After injection, the oocytes were cultured for 24 h in TCM-199 medium containing 4 mM dbcAMP. The oocytes were then transferred to fresh TCM-199 medium and cultured for 48 h. For depleting Cdk2 in zygotes, 10 pl (1 lg/ll) dsRNA was microinjected into parthenogenetically activated oocytes and then cultured in PZM-5 medium. The control oocytes or zygotes were microinjected with 10 pl of water.
Immunofluorescence Analysis
Oocytes or embryos were washed with PBS, fixed in 3.7% paraformaldehyde (w/v) in PBS containing 0.1% PVA, and permeabilized with 1% Triton X-100 (v/v) for 1 h at 378C. The samples were blocked with 1% BSA (w/v) for 1 h, incubated overnight with the appropriate antibody at 48C in a blocking solution, and washed with 1% BSA. The primary antibodies used were rabbit anti-cH2AX (pS139, 1:100; cat. no. 2577; Cell Signaling Technology), rabbit anti-CDK2 (1:100; cat. no. SAB4503706; Sigma-Aldrich), rabbit anti-53BP1 (1:100; cat. no. 4937; Cell Signaling Technology), and goat anti-OCT4 (1:100; cat. no. sc-8628; Santa Cruz Biotechnology). The oocytes or embryos were washed three times with PBS containing 1% BSA and were labeled with a fluorescein isothiocyanate (FITC)/Texas Red-conjugated secondary antibody (1:100) for 1 h at RT. The oocytes were then counterstained with 5 lg/ml Hoechst 33342 (bisBenzimide H33342 trihydrochloride; Sigma Life Science) for 15 min, washed three times with PVA-PBS, mounted on a glass slide, and examined using an LSM 710 META confocal laser-scanning microscope (Zeiss). The cH2AX foci larger than 0.3 lm 3 in each nucleus were considered to be DSB sites.
Fluorescence Intensity Analysis
ImageJ software (v.1.47) was used to define a region of interest (ROI), and the average fluorescence intensity per unit area within the ROI was determined. Independent measurements using identically sized ROIs were made for the cell nucleus or cytoplasm. The average values of all measurements were used to compare the final average intensities between control and treated oocytes.
Western Blot Analysis
Western blotting was performed as described previously [7] . A total of 300 porcine embryos per sample were placed in 13 SDS sample buffer and heated at 1008C for 5 min. Proteins were separated by SDS-PAGE and transferred to polyvinylidene fluoride membranes. Thereafter, membranes were blocked in Tris-buffered saline containing 0.1% Tween 20 (TBS-T) containing 5% nonfat milk for 1 h and were then incubated at 48C overnight with rabbit anti-P53 (1:1000; cat. no. sc-6243; Santa Cruz Biotechnology), mouse anti-P21 (1:1000; cat. no. P1484; Sigma-Aldrich), rabbit anti-ATM (pS1981, 1:1000; cat. no. 13050; Cell Signaling Technology), or mouse anti-b-actin antibodies (1:1000; cat. no. 3700; Cell Signaling Technology). Membranes were washed three times with TBS-T (10 min each) and incubated at 208C for 1 h with horseradish peroxidase-conjugated goat anti-rabbit-IgG or anti-mouse-IgG (1:1000; Santa Cruz Biotechnology). Signals were detected using Pierce ECL Western blotting substrate (Thermo Fisher Scientific). To quantify Western blot results, band intensity values were determined using ImageJ software.
Quantitative RT-PCR with SYBR Green
Total RNA was extracted using the Dynabeads mRNA Direct Kit (Dynal Asa) according to the manufacturer's instructions. First-strand cDNA was synthesized by reverse transcription of mRNA using the Oligo (dT) 12-18 primer and SuperScript III Reverse Transcriptase (Invitrogen Co.). Real-time PCR (also called quantitative PCR [qPCR]) was performed using a CFX96 Touch Real-Time PCR Detection System (Bio-Rad) in a final reaction volume of 20 ll including SYBR Green, a fluorophore that binds dsDNA (qPCR kit from Finnzymes). The PCR conditions were as follows: 958C for 10 min followed by 39 cycles of 958C for 30 sec, 608C for 30 sec, and 728C for 25 sec, and a final extension at 728C for 5 min. Finally, gene expression was quantified using the 2
ÀDDCt method and normalized against the mRNA levels of glyceraldehyde 3-phosphate dehydrogenase (Gapdh). The primers used to amplify each gene are shown in Supplemental Table S1 (all supplemental data are available online at www.biolreprod.org).
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TUNEL Assay
Embryos were washed three times with PBS (pH 7.4) containing 1 mg/ml polyvinylpyrrolidone (PBS/PVP). After fixation for 1 h at RT with 3.7% paraformaldehyde prepared in PBS, the embryos were washed with PBS/PVP and permeabilized by incubation in 0.5% Triton X-100 for 1 h at RT. The embryos were then washed twice with PBS/PVP and incubated with fluorescein-conjugated dUTP and terminal deoxynucleotidyl transferase (In Situ Cell Death Detection Kit; Roche) in the dark for 1 h at 378C. Blastocysts were counterstained with Hoechst 33342 to label all nuclei, washed with PBS/ PVP, mounted with slight coverslip compression, and examined under an Olympus fluorescence microscope.
Comet Assay
Comet assays were performed using an OxiSelect Comet Assay Kit (cat. no. STA-350; Cell Biolabs). Prior to the assay, OxiSelect comet agarose was melted at 908C for 20 min and then cooled at 378C for 20 min. About 75 ll of agarose was then dropped onto an OxiSelect 3-well comet slide, after which approximately 20 zona-free embryos were transferred to agarose drops and chilled at 48C for 20 min. The samples were then lysed in lysis buffer (250 mM NaCl, 20% EDTA solution, 10% DMSO, 10% 103 kit lysis solution, pH ;10.0) at 48C for 2 h. Next, the slides were carefully transferred to a chilled alkaline solution (300 mM NaOH, 1 mM EDTA) and immersed for 30 min at 48C. Subsequently, the slides were transferred to a horizontal electrophoresis chamber filled with cold TAE buffer and electrophoresed for 20 min at 25 V, after which the slides were stained with 13 Vista Green DNA Dye for 15 min and then examined using a fluorescent microscope with an FITC filter. All steps after the agarose treatment were conducted in the dark to prevent additional DNA damage. The comet tail lengths were measured in individual embryos using CASP (ver. 1.2.3beta2; Zbigniew Koza).
Statistical Analysis
Each experiment was performed at least three times and at least 30 oocytes or 20 embryos were examined in each replicate. Statistical analyses were performed using the SPSS software package (Version 11.5; SPSS). Continuous data were analyzed using ANOVA, and means were compared using Student ttest or Tukey-Kramer honestly significant difference test for single or multiple comparisons, respectively. Data are expressed as mean 6 SD, and a P value , 0.05 was considered statistically significant.
RESULTS
CDK2 Expression and Localization in Porcine Oocytes and Early Embryos
We first examined the subcellular localization of CDK2 at different stages of oocyte maturation and early embryo development by immunofluorescent staining. Oocytes were first cultured for 0, 24, 26, 30, or 44 h, which corresponded to the times to achieve GV, GV breakdown (GVBD), MI, anaphase/telophase (ATI), and MII stages, respectively. As shown in Figure 1A , CDK2 was localized in the cytoplasm during the GV stage. After GVBD, CDK2 colocalized with atubulin. In the MI, ATI, and MII stages, CDK2 also colocalized with the spindles. To determine whether CDK2 was expressed in embryos, parthenogenetically activated oocytes were used. CDK2 protein localization was examined in the following samples: zygotes, two-, four-, and eight-cell, morula, and blastocyst embryos. As shown in Figure 1B and Supplemental Figure S1 , CDK2 was predominantly located in the cytoplasm during all embryonic stages. Next, Cdk2 transcripts were detected by quantitative RT-PCR. As shown in Figure 1C , transcripts of Cdk2 were reduced until the four-cell stage and then significantly increased at the blastocyst stage.
CDK2 Activity Is Not Essential for Meiotic Resumption or MII Arrest in Porcine Oocytes
To assess whether CDK2 is required during porcine meiotic maturation, we inhibited CDK2 activity using a highly selective inhibitor, CDK2 inhibitor II, and knocked down the expression of Cdk2 using dsRNA. The level of CDK2 mRNA was significantly decreased after dsRNA injection ( Fig. 2A) . Knockdown of CDK2 was also confirmed at the protein level by immunostaining (Fig. 2, B and C) . For inhibitor treatment, COCs were treated with CDK2 inhibitor at different doses for 48 h, after which the meiotic maturation competence of the oocytes was evaluated. As shown in Figure 2D , the expansion of the peripheral cumulus layers reached greater than five layers in the control group, whereas it became progressively worse in the inhibitor-treated COCs. Moreover, most (87.68%) control oocytes underwent GVBD at 24 h of culture, whereas only 57.67%, 35.67%, and 32.33% of the 2.5-, 5-, and 10-lM CDK2 inhibitor-treated COCs, respectively, underwent GVBD at 24 h. After 32 h of treatment with 2.5-, 5-, or 10-lM CDK2 inhibitor, the rate of GVBD increased to 88.83%, 81.5%, and 74.59%, respectively (Fig. 2E) . However, it is worth noting that the polar body extrusion (PBE) rate of CDK2 inhibitortreated oocytes (97.03%, n ¼ 236 COCs) was comparable with control oocytes (97.77%, n ¼ 90 COCs) after 48 h of culture (Fig. 2F) . To exclude the effects of cumulus cells on oocyte maturation, denuded oocytes (DOs) were treated with 10 lM of CDK2 inhibitor (Fig. 2, G and H) . Control DOs underwent GVBD (24 h) and extruded polar bodies (48 h) at rates of 64.65% and 60.17%, respectively (n ¼ 85 and 93 DOs), and CDK2 inhibitor treatment did not significantly change these rates (61.26% and 55.59%; P , 0.05; n ¼ 79 and 83 DOs). Normal GVBD (24 h) and PBE (48 h) were also seen in Cdk2 knockdown groups (Fig. 2, I and J). Upon spindle staining after 48 h of culture, we further confirmed that CDK2 inhibitortreated (10 lM) oocytes normally undergo MII arrest (Fig. 2K) . These results suggest that CDK2 is dispensable for meiotic resumption or transition from MI to MII.
CDK2 Inhibition Affects the Early Cleavage of Porcine Embryos
To investigate a role for CDK2 in embryo development, zygotes, produced by the parthenogenetic activation of MII oocytes, were immediately cultured in vitro in medium supplemented with CDK2 inhibitor to monitor their ability to undergo cleavage divisions. In the control group (0 lM CDK2 inhibitor), 67.05% and 90.43% of the embryos had cleaved at 24 h and 30 h, respectively (Fig. 3A) . However, only 40.47%, 35.87%, and 33.20% of the 2.5-, 5-, and 10-lM CDK2 inhibitor-treated embryos, respectively, had cleaved at 24 h. After 30 h of treatment with 2.5-, 5-, or 10-lM CDK2 inhibitor, the rate of cleavage increased to 89.75%, 85.33%, and 81.24%, respectively (Fig. 3A) . Although a significant proportion of CDK2 inhibitor-treated (5 lM) embryos could develop beyond the first cleavage stage, the embryo quality was poor, showing more micronuclei or abnormal nucleus numbers (35.2%, n ¼ 62 embryos) than the control (8.71%, n ¼ 69 embryos) group embryos (Fig. 3B) . The ability of the CDK2 inhibitor-treated embryos to develop to the blastocyst stage was dramatically reduced (Fig. 3, C and D) . Development to blastocyst stage was almost completely blocked by 10 lM (10.41%) of CDK2 inhibitor treatment at Day 7, whereas it was reduced approximately 50% by 5-lM treatment (29.67%) when compared with the control embryos (52.22%) (Fig. 3D) . The numbers of cells per blastocyst were lower in the CDK2 inhibitor treatment groups than in the controls (Fig. 3C) . Most of the CDK2 inhibitor-treated embryos were arrested at the two-to four-cell stage, although most of the embryos in the control group had already reached the morula or early blastocyst stage after 5 days of development (Fig. 3E) . These results show that CDK2 inhibition resulted in early parthenogenetic embryo development failure in a dose-dependent manner. With the use of fertilized embryos, we further confirmed that CDK2 inhibitor treatment impaired early embryo development (Supplemental Fig. S2A ). Thus, CDK2 is critical for the early cleavage of porcine embryos. A CDK2 inhibitor concentration of 5 lM was used for all subsequent studies with porcine embryos.
Disruption of CDK2 Induces DNA Damage in Early Preimplantation Embryos
If CDK2 plays a role in DNA repair, it is possible that CDK2 knockdown could lead to increased accumulation of DNA damage. To test this hypothesis, we examined cH2AX, which is the DNA repair signal marker for DNA DSBs, in parthenogenetic embryos that had been exposed to CDK2 inhibitor (Fig. 4) . The presence of phosphorylated H2AX was examined after treatment with 5 lM of CDK2 inhibitor. We detected a lower number of cH2AX foci in the nuclei of control embryos than in CDK2 inhibitor-treated embryos (P , 0.001) on Day 3 (Fig. 4, A and B ) of development. Our results suggest higher levels of DNA DSBs in CDK2 inhibitor-treated embryos. Further analysis at Day 5 of development again indicated a higher number of cH2AX foci in CDK2 inhibitortreated embryos (Fig. 4, D and E) . Using dsRNA targeting Cdk2, we confirmed the presence of high levels of phosphorylated H2AX after CDK2 knockdown (Fig. 4, C and F) . To further confirm that CDK2 has the same function in fertilized embryos, we treated fertilized embryos with 5 lM CDK2 inhibitor. Consistent with the DNA damage accumulation in parthenogenetic embryos, we observed that cH2AX foci also increased in fertilized embryos after CDK2 inhibition (Supplemental Fig. S2, B and C) . This result reveals the accumulation of DSBs in both parthenogenetic and fertilized embryos after CDK2 disruption. DNA comet assay results further confirmed that DNA damage occurs in CDK2-inhibited parthenogenetic embryos (Supplemental Fig. S3 ). This could be due to either continuous generation of DNA damage or low FIG. 3 . Effects of CDK2 inhibition on the early cleavage of porcine parthenogenetic embryos. A) Cleavage rates of porcine embryos that were untreated (control) or exposed to 2.5, 5, or 10 lM CDK2 inhibitor. The most suitable concentration for use with embryos was 5 lM. Cleavage rates were determined 24 and 30 h after parthenogenetic activation. B) Morphology of embryos derived from zygotes treated with CDK2 inhibitor (5 lM). For embryos that were treated with CDK2 inhibitor, two nuclei or no nuclei were found in each blastomere. Blue, chromatin; DIC, differential interference contrast. Bar ¼ 20 mm. C) Morphology of Day-7 embryos derived from zygotes treated with CDK2 inhibitor (5 lM), indicating that the blastocyst rates and cell numbers per blastocyst were lower than in control group. D) Blastocyst rates of porcine embryos that were untreated (control) or exposed to 2.5, 5, or 10 lM CDK2 inhibitor. E) The rate of development of embryos treated with CDK2 inhibitor over 7 days in culture. *P , 0.05; **P , 0.01; ***P , 0.001. 
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repair efficiency. Due to the similar role of CDK2 in normally fertilized and parthenogenetic embryo development, we used parthenogenetic embryos for all subsequent experiments.
CDK2 Inhibition-Mediated Activation of the ATM-P53-P21-Dependent Cell Cycle Checkpoint
We next sought to identify the downstream effector of CDK2 inhibition in porcine embryos. Previous studies have found that downregulation of CDK2 triggers the G1 checkpoint through activation of the P53 pathway. Preimplantation embryo development has been shown to require the latency of P53, and increased expression of P53 is associated with poor developmental potential [29, 30] . Therefore, we tested whether CDK2 inhibition could lead to an increase in P53 and its downstream target P21 in preimplantation embryos (Fig. 5) , resulting in impaired development. Western blot results showed that P53 (Fig. 5C ) and P21 proteins (Fig. 5D) were increased after two-cell embryos were treated with the CDK2 inhibitor. At the same time, the phosphorylated forms of ATM (ATM-p) also increased after CDK2 inhibitor treatment (Fig.  5B) . These findings indicate that the ATM-P53-P21 checkpoint pathway was activated after CDK2 inhibition.
CDK2 Inhibition Decreases the Expression of DNA Repair Genes
The phosphorylation of histone H2AX is critical for DSB repair, because H2AX anchors some of the important initiator proteins that are required for both HR (e.g., RAD51, MRE11A, BRCAL) and NHEJ (e.g., 53BP1, PRKDC, XRCC6) pathways, which can be colocalized with cH2AX at the sites of DSBs [15, 16] . To explore the effect of CDK2 inhibitor treatment on DSB repair, mRNA levels of DNA damage response genes participating in the HR and NHEJ repair pathways were measured in 5-day-old embryos. CDK2 inhibitor-treated embryos had lower mRNA levels of genes involved in HR (Rad51, Mre11a) and NHEJ (53bp1, Prkdc, Xrcc6) compared with that in nontreated embryos on Day 5 (Fig. 6A) . With the use of specific antibodies, we confirmed that 53BP1 foci also decrease after CDK2 inhibition (Supplemental Fig. S4 ). In contrast to findings in Day-5 embryos, the levels of mRNA expression for the studied genes involved in the HR and NHEJ repair pathways were increased in 7-day-old blastocysts (Fig. 6B) . Additionally, there was no difference in the levels of cH2AX foci in 7-day-old blastocysts between control and CDK2-inhibited blastocysts (data not shown). 
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These results suggest that only the embryos that have high repair efficiency were able to develop to the blastocyst stage.
CDK2 Inhibition Leads to Increased Apoptosis and Decreased Expression of Pluripotency Markers
Apoptosis is a recognized response of cells with excessive DNA damage. The rate of apoptosis was calculated by dividing the number of cells with TUNEL-positive nuclei by the total embryo cell number. The number of TUNEL-positive nuclei was increased on Day 7 in the CDK2 inhibitor-treated group (Fig. 7, A and B) . We also observed decreased expression of Bcl-xl after CDK2 inhibition. However, expression of other apoptotic genes, such as Casp3 and Bax, increased (Fig. 7C) , suggesting that CDK2 may play a role in modulating apoptosis during porcine embryo development. Furthermore, the expression of three pluripotency-related genes, Oct4, Sox2, and Nanog, was lower in CDK2 inhibitor-treated (5 lM) embryos 
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than in nontreated embryos at the blastocyst stage (Fig. 7, D-F) . These findings indicate that the embryo quality was influenced by CDK2 inhibitor treatment.
DISCUSSION
In this study, we employed porcine embryos, which have many similarities to human oocytes [26] . Therefore, they are an excellent system for modeling human reproduction in order to investigate the possible functions and mechanisms of CDK2 during oocyte meiotic maturation and embryo development. First, using an inhibitor and dsRNA targeting Cdk2, we found that CDK2 activity is not essential for meiotic resumption or MII arrest in porcine oocytes. Second, we found that CDK2 inhibition induces accumulation of DNA damage and arrests preimplantation development though activation of the ATM-P53-P21 pathway. Third, we also found that CDK2 inhibition influences the transcript levels of HR and NHEJ DNA repair pathway genes, as summarized in Figure 8 . Our results also indicate that CDK2 may have a role in the execution of apoptosis.
Previously, CDK2 involvement in the progression of meiotic maturation has been studied only in Xenopus oocytes [29] [30] [31] , and research has produced conflicting results. The results of studies injecting CDK2 antisense RNA into immature oocytes [30] and adding active CDK2/cyclin E complexes in oocyte extracts [31] indicated important roles for CDK2 activity during the meiotic cell cycle. Previous studies using antibody injection indicated that CDK2 activity is required for the normal progression of porcine oocyte meiosis, especially for entering MII [24] . In contrast, a study using the CDK2 inhibitor P21 showed that CDK2 activity was dispensable for oocyte meiosis [32] . The results of these experiments are inconsistent, and our results show that CDK2 is not required for meiotic resumption or MII arrest in porcine oocytes using a selective inhibitor of CDK2 [33] and RNAi knockdown. Consistent with our results, Adhikari et al. deleted CDK1 and CDK2 from mouse oocytes and provided genetic evidence that CDK1, but not CDK2, is indispensable for triggering the resumption of meiosis in mouse oocytes [34] .
Given that CDK2 has no function during oocyte maturation, we next wanted to investigate the role of CDK2 in embryo development. There is evidence to suggest that CDK2 plays an indirect role in DNA repair by activating several proteins involved in repair pathways. This is supported by many studies with cancer cell lines, showing that CDK knockdown or inhibition of activity delays the normal activation of DNA damage signaling, slows the rate of DNA repair, and prolongs the persistence of DSBs [4, 35] . This response is enhanced when CHK1 function is compromised, especially under conditions of replication stress [33] . In this experiment, inhibiting CDK2 arrested cell division and decreased blastocyst rate. Our previous studies also show that etoposide-induced DNA DSBs delayed embryo cleavage and ceased embryo development before the blastocyst stage [36] . Therefore, we hypothesized that CDK2 knockdown-induced cell cycle arrest may be caused by increased accumulation of DNA damage during early embryonic development. Indeed, by analyzing the number of cH2AX fluorescent foci [37, 38] , we demonstrated that CDK2 knockdown embryos have more DNA DSBs than control embryos on Days 3 and 5 of development.
In response to DNA damage, cell cycle checkpoints (G1, S, G2/M) are activated, stopping cell cycle progression to allow time for repair, thereby preventing transmission of damaged or incompletely replicated chromosomes [3] . CDK2/cyclin E complexes are inhibited to arrest cells at the G1/S checkpoint, whereas Cdk1/cyclin B complexes are inhibited to arrest the cells at the G2/M phase of the cell cycle [39] . The G1 cell cycle checkpoint is primarily responsible for preventing damaged DNA from being replicated. During G1/S DNA damage checkpoint arrest, ATM/ATR-mediated activation of P53 activates one of its downstream targets, P21 [40] . P21 binds to and inhibits CDK2/cyclin E complexes, thereby arresting cells at the G1/S transition. As a result, CDK2 has become the prime target of the G1/S DNA damage checkpoint, and CDK2 inhibition by P21 is an essential step in maintaining the G1/S DNA damage checkpoint [3] . Our results show that parthenogenetic embryos that had been treated with CDK2 inhibitor were arrested at approximately the two-or four-cell stage. In addition, we found that P53 and P21 proteins were increased at the two-cell stage, and we found higher levels of ATM-p in CDK2 inhibitor-treated embryos. This indicates that CDK2 inhibition induces accumulation of DNA damage and activates an ATM-P53-P21-dependent cell cycle checkpoint in response to damaged DNA, as illustrated in Figure 8 . Therefore, their arrest prior to the completion of DNA repair suggests that the DNA damage checkpoint mechanisms are functioning sufficiently in embryos with inhibited CDK2. A possible reason is that CDK1 can compensate for CDK2 when CDK2 activity is impaired [18] .
In order to evaluate the effect of CDK2 on DSB repair in porcine embryos, we assessed the expression of several genes involved in either the HR or the NHEJ pathway in CDK2 inhibitor-treated embryos at Days 5 and 7 of development. In this study, we observed decreased expression of genes involved in the HR and NHEJ repair pathways in Day-5 embryos that were treated with CDK2 inhibitor. Lower expression of DNA repair genes indicates that Day-5 embryos treated with CDK2 inhibitor have lower repair efficiency. In contrast with Day-5 embryos, we observed that most of the assessed genes were expressed normally in Day-7 blastocysts. These results suggest that only the embryos that had a high level of DNA damage repair genes are able to develop to the blastocyst stage. These data suggest that, although the CDK2 inhibitor-treated embryos activate an ATM-P53-P21 checkpoint and arrest cell division, this damage is not fully repaired during the cell cycle arrest. This low repair efficiency in CDK2 inhibitor-treated embryos could be due to the influence of several genes involved in either the HR or the NHEJ pathway.
The decreased expression of several genes involved in either the HR or the NHEJ pathway in porcine Day-5 embryos treated with CDK2 inhibitor may be caused by altered zygotic gene activation (ZGA) after CDK2 inhibition. Previous studies show that the CDK2/cyclin A2 complex regulates ZGA in one-cell mouse embryos [41] . Porcine ZGA was confirmed to occur between the four-and eight-cell stages via genome-wide gene FIG. 8 . Schematic figure depicting the role of CDK2 in checkpoint activation and the downstream effects on DNA repair and apoptosis during porcine early embryonic development. CDK2 activity is not essential for meiotic resumption or MII arrest in porcine oocytes. However, CDK2 inhibition induces accumulation of cH2AX and activation of an ATM-P53-P21 checkpoint pathway, which arrests porcine preimplantation development at approximately the two-or four-cell stage. CDK2 inhibition also influences the transcript levels of HR and NHEJ DNA repair pathways at Day 5, which may be caused by changed ZGA after CDK2 inhibition. CDK2 may have a role in the execution of apoptosis.
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expression analysis, compensating for the loss of maternal transcripts [42] . Thus, if a DNA repair gene were insufficiently transcribed, its transcripts would decrease to a low level at the one-or two-cell stage. These levels may increase again after the four-cell stage, allowing functional DNA damage repair to occur. This hypothesis is supported by our previous observation that etoposide-induced DNA DSBs arrest cell division at approximately the four-cell stage in porcine embryos [36] .
In response to DSBs, the DNA damage checkpoint arrests the cell cycle and gives more time for the cells to repair the DNA damage, but, in some cases, this arrest can lead to the activation of apoptotic pathways [36] . We used TUNEL staining as a means of detecting apoptosis in the CDK2 inhibitor-treated embryos. Our observations of enhanced apoptosis after CDK2 inhibition and a possible interaction between CDK2 and apoptosis-related genes lead us to speculate that CDK2 may have a role in the execution of apoptosis.
How could pluripotency-related genes (Oct4, Sox2, and Nanog) be decreased after CDK2 inhibition? One possible reason is that CDK2 inhibition induces DNA damage and apoptosis, and influences the expression of pluripotencyrelated genes. Consistent with this observation, our previous studies show that etoposide-induced DNA DSBs increase apoptosis and decrease the expression of Oct4, Sox2, and Nanog in porcine early embryos. In addition, laser microbeaminduced DNA damage in blastomeres of mouse early embryos also showed faint staining for OCT4 and CDX2 [43] , further supporting that decreased expression of Oct4, Sox2, and Nanog were due to CDK2 inhibition-induced DNA damage and apoptosis. However, we cannot exclude the possibility that CDK2 may directly influence Oct4, Sox2, and Nanog expression. A recent study showed that CDK2 inhibition influences the expression of pluripotency markers of NANOG, OCT4, and SOX2 in human embryonic stem cells [44] . More recently, CDK2 was found to modulate the ability of OCT4, SOX2, and KLF4 to reprogram fibroblasts back into pluripotent stem cells by phosphorylation of mouse SOX2 [45] . Further investigations are required to clarify CDK2-mediated pluripotency-related gene regulation.
In conclusion, our results suggest that, although loss of CDK2 did not affect porcine meiotic maturation, CDK2 plays a number of important roles in porcine preimplantation embryonic development, ranging from cell cycle regulation to checkpoint activation and DNA repair. Further studies should investigate which CDK2 interacting partners are involved in this multiplex process.
